Wilson Sonsini Goodrich & Rosati advised Alleviant Medical on the transaction. Alleviant Medical, Inc., a privately held medical device company, announced a $90 million financing to...
Alleviant Medical’s $90 Million Equity Financing
Microchip Technology’s $2 Billion Investment Grade Notes Offering
Wilson Sonsini Goodrich & Rosati advised Microchip on the transaction, and Simpson Thacher & Bartlett represented the underwriters. Microchip Technology Incorporated (Microchip) priced an offering of...
Lumos Pharma’s Tender Offer and Merger with Double Point Ventures
Wilson Sonsini Goodrich & Rosati and Cooley advised Lumos Pharma on the transaction, while Foley & Lardner advised Double Point Ventures. Lumos Pharma (NASDAQ:LUMO), a clinical...
Tenstorrent’s $693 Million Series D Financing Round
Wilson Sonsini Goodrich & Rosati advised Tenstorrent on the transaction. Tenstorrent, a next-generation computing company that builds computers for AI, announced the closing of over $693...
Seismos and Edison’s $15 Million Growth Investment
Wilson Sonsini Goodrich & Rosati advised Seismos on the transaction. Seismos, Inc., a leader in AI-powered Acoustic Sensing, and growth equity firm Edison Partners announced a...
BurnBot’s $20 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised BurnBot on the transaction. BurnBot announced it has secured $20 million in financing to expand its mechanized vegetation management and...
Linden Capital Partners’ Acquisition of Alcresta Therapeutics
Kirkland & Ellis represented Linden Capital Partners, Wilmer Cutler Pickering Hale and Dorr represented Alcresta Therapeutics and Wilson Sonsini Goodrich & Rosati advised HealthQuest Capital. Linden...
Microchip Technology’s $1 Billion Senior Notes Offering
Wilson Sonsini Goodrich & Rosati represented Microchip Technology Incorporated in the offering, and Simpson Thacher & Bartlett represented the underwriters. Microchip Technology Incorporated (Microchip) (Nasdaq: MCHP) priced...
Procyrion’s $57.7 Million Series E Financing Round
Cooley advised Procyrion on the transaction, and Wilson Sonsini Goodrich & Rosati advised lead investor Fannin Partners. Procyrion, Inc. announced it completed a $57.7 million Series E...
Tenstorrent’s $100 Million Financing Round
Wilson Sonsini Goodrich & Rosati represented Tenstorrent in the transaction. Tenstorrent announced that it closed a $100 million strategic financing up-round led by Hyundai Motor Group...
Amaero’s Flagship Titanium Project in Tennessee
Wilson Sonsini Goodrich & Rosati advised Amaero International Limited in the deal. A global leader in titanium, Amaero International Limited, announced that it has green lighted its flagship titanium...
Alleviant Medical’s $75 Million Equity Financing
Wilson Sonsini Goodrich & Rosati represented Alleviant Medical in the transaction. Alleviant Medical, Inc., a privately-held medical device company developing a no-implant interatrial shunt for heart...